The company was established in Asia in China. The leading representative office of defined VC is situated in the Hangzhou.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2019. The top activity for fund was in 2018.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Hangzhou Just Biotherapeutics (Just China). Among the most successful fund investment fields, there are Biopharma, Medical.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the BOCGI Zheshang Capital, startups are often financed by Lilly Asia Ventures, ARCH Venture Partners, Merck. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Taikang Asset, Lilly Asia Ventures.
Related Funds
Fund Name | Location |
AARP | District of Columbia, United States, Washington |
Aventrock Ventures | Alberta, Calgary, Canada |
Beijing Wenhua Haihui | Beijing, Beijing, China |
Central Exchange | China, Hong Kong, Hong Kong Island |
EuroFinLeading Private Equity | - |
Impres Health | - |
Investo Capital | Aalborg, Denmark, North Denmark Region |
PEI Funds | New York, New York, United States |
Prudence Venture Investment Corporation | - |
QUBIS | Belfast, Northern Ireland, United Kingdom |
Selva Ventures | California, San Francisco, United States |
SIOS Technology Corp. | California, San Mateo, United States |
Suzhou Haihui Jijin | China, Jiangsu, Suzhou |
The Westly Group | California, Menlo Park, United States |
UnityVC | Beijing, Beijing, China |
usednet | Japan, Saitama, Saitama Prefecture |
Venture Capital Catalyst Initiative (VCCI) | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Hangzhou Just Biotherapeutics (Just China) | $35M | 06 Jun 2018 | Zhejiang | ||
WENSLI | $463K | 28 Nov 2016 | Shangcheng District, Zhejiang, China | ||
WINIT | $1M | 20 Jun 2016 | Futian District, Guangdong Province, China | ||
Xin Yunlian | $463K | 30 Oct 2015 | Yinzhou District, Zhejiang, China | ||
Aiyoumi | $46M | 13 Sep 2015 | Shangcheng District, Zhejiang, China | ||
Zhongce Che Kongjian | $3M | 28 Nov 2014 | China, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Hangzhou Just Biotherapeutics (Just China) | $35M | 06 Jun 2018 | Zhejiang | ||
WENSLI | $463K | 28 Nov 2016 | Shangcheng District, Zhejiang, China | ||
WINIT | $1M | 20 Jun 2016 | Futian District, Guangdong Province, China | ||
Xin Yunlian | $463K | 30 Oct 2015 | Yinzhou District, Zhejiang, China | ||
Aiyoumi | $46M | 13 Sep 2015 | Shangcheng District, Zhejiang, China | ||
Zhongce Che Kongjian | $3M | 28 Nov 2014 | China, Zhejiang |